Medicare Enrolled
Dr. Adrian Escontrias, M.D.
Anesthesiology · El Paso, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Escontrias from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Escontrias?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Escontrias
Dr. Adrian Escontrias is an anesthesiology specialist in El Paso, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Escontrias performed 5,880 Medicare services across 1,448 unique beneficiaries.
Between the years covered by Open Payments, Dr. Escontrias received a total of $2,289 from 23 pharmaceutical and/or device companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in anesthesiology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Escontrias is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in TX
$2,289 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,880
Medicare services
Top 1% in TX for anesthesiology
1,448
Unique beneficiaries
$66
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~309 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
955 | $61 | $548 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
952 | $112 | $2,164 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
940 | $84 | $375 |
| Injection, propofol, 10 mg | 870 | $0 | $2 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
761 | $1 | $6 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
335 | $66 | $275 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
109 | $43 | $349 |
| Injection of anesthetic agent and/or steroid into other nerve or branch | 106 | $58 | $4,848 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
87 | $41 | $1,373 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
76 | $83 | $671 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
72 | $48 | $270 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
54 | $110 | $460 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
47 | $189 | $6,006 |
| Facial nerve injection with anesthetic and/or steroid An injection of an anesthetic agent and/or steroid into the facial nerve. This procedure delivers medication directly to the nerve. |
46 | $124 | $5,421 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
43 | $103 | $4,086 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
36 | $443 | $10,729 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
36 | $42 | $175 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
33 | $187 | $4,806 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
33 | $261 | $3,268 |
| Other procedure on nervous system A surgical or medical intervention performed on the nervous system that does not fall under other specific categories. |
33 | $28 | $2,654 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
29 | $98 | $2,399 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
28 | $463 | $10,124 |
| Destruction of peripheral nerve or branch | 26 | $180 | $8,120 |
| Injection, methylprednisolone acetate, 40 mg | 26 | $6 | $67 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
25 | $250 | $2,932 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
22 | $102 | $4,500 |
| Tendon injection at attachment site A procedure involving the injection of medication into a tendon where it attaches to bone or muscle. |
18 | $42 | $3,333 |
| Destruction of nerve branches of knee using imaging guidance | 18 | $283 | $6,493 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
17 | $53 | $362 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $85 | $300 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
16 | $0 | $200 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
15 | $10 | $250 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$2,289
Total received (2018-2024)
Avg $327/year across 7 years
Top 12% in TX for anesthesiology
23
Companies
88
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,289 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$168
2023
$155
2022
$83
2021
$113
2020
$190
2019
$840
2018
$741
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$659
BioDelivery Sciences International, Inc.
$232
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$218
ABBVIE INC.
$146
SI-BONE, Inc.
$109
Novartis Pharmaceuticals Corporation
$108
Nevro Corp.
$103
Collegium Pharmaceutical, Inc.
$103
US WorldMeds, LLC
$88
VERTEX PHARMACEUTICALS INCORPORATED
$80
Kaleo, Inc.
$61
AbbVie Inc.
$57
Lilly USA, LLC
$50
Allergan, Inc.
$41
PFIZER INC.
$38
BOSTON SCIENTIFIC CORPORATION
$35
Boston Scientific Corporation
$32
Upsher-Smith Laboratories LLC
$32
Biohaven Pharmaceuticals, Inc.
$31
Daiichi Sankyo Inc.
$19
Teva Pharmaceuticals USA, Inc.
$18
Scilex Pharmaceuticals Inc.
$16
FIDIA PHARMA USA INC.
$14
Top 3 companies account for 48.5% of total payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · BELBUCA · BOTOX · BUNAVAIL 2.1 mg 30-count box · EMGALITY · Evzio · GENERAL PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · Hymovis · LYRICA · Lamitrode SCS Leads · MYOBLOC · Morphabond ER · NURTEC ODT · Neuromodulation Dspsbls and Accs · Octrode SCS Leads · PROCLAIM · Penta SCS Leads · Proclaim Family of SCS IPGs · Prodigy Family of SCS IPGs · QULIPTA · RELISTOR · SPECTRA WAVEWRITER · Senza Spinal Cord Stimulation System · TOSYMRA SUMATRIPTAN NASAL SPRAY · UBRELVY · XTAMPZA · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $39 per 100 Medicare services performed
Geographic Context
Anesthesiologists within 10 mi
74
Per 100K population
8.5
County median income
$58,859
Nearest hospital
UNIVERSITY MEDICAL CENTER OF EL PASO
4.3 mi
4.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Escontrias is a clinical cardiology specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement in the top 12% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Escontrias experienced with drug screening test?
Based on Medicare claims data, Dr. Escontrias performed 955 drug screening test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Escontrias receive payments from pharmaceutical companies?
Yes. Dr. Escontrias received a total of $2,289 from 23 companies across 88 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Escontrias's costs compare to other anesthesiologists in El Paso?
Dr. Escontrias's average Medicare payment per service is $66. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Escontrias) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Anesthesiologists in El Paso
Browse anesthesiologists in El Paso ranked by procedure volume and transparency data.
Highest volume
Top Anesthesiologists in TX
Anesthesiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Anesthesiologists in TX
Which TX anesthesiologists receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
BioDelivery Sciences International, Inc. Payments to Doctors
See all physicians who received payments from BioDelivery Sciences International, Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology